Literature DB >> 12558235

Hemorrhage after coronary artery bypass graft procedures.

Loreen A Herwaldt1, Sheri K Swartzendruber, M Bridget Zimmerman, David A Scholz, Jo Ann Franklin, Christopher A Caldarone.   

Abstract

OBJECTIVES: To identify risk factors for excessive bleeding after coronary artery bypass graft (CABG) procedures and to quantify the outcomes related to this complication.
DESIGN: We conducted a case-control study to identify risk factors for hemorrhage following CABG surgery and a historical cohort study to quantify outcomes of hemorrhage.
SETTING: The cardiothoracic surgery service of a university hospital.
RESULTS: Factors associated with excessive blood loss were recent catheterization (odds ratio [OR] = 0.44; 95% confidence interval [CI95], 0.21 to 0.91); age older than 65 years (OR = 1.94; CI95, 0.96 to 3.93); bypass time of 150 minutes or more (OR = 2.91; CI95, 1.09 to 7.81); and postoperative platelet count of 160,000/mm3 or less (OR = 2.36; CI95, 1.06 to 5.22). The attributable cost of a postoperative hemorrhage was $3,866 (P = .0002) overall, $9,912 (P = .0001) for patients who required reoperation, and $3,316 (P = .03) for those treated medically. The median attributable postoperative length of stay was 1 day longer for cases than for controls (P = .011). Postoperatively, patients who hemorrhaged received significantly larger volumes of packed red blood cells (P < .0001), fresh frozen plasma (P < .0001), platelets (P < .0001), plasminate (P = .007), protamine sulfate (P < .0001), desmopressin acetate (P < .0001), and epsilon-aminocaproic acid (P < .0001) than did controls.
CONCLUSIONS: Age, duration of bypass, and postoperative platelet count were associated with excessive bleeding. Hemorrhage after CABG surgery significantly increased the length of stay and cost of care.

Entities:  

Mesh:

Year:  2003        PMID: 12558235     DOI: 10.1086/502114

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  7 in total

Review 1.  The REG1 anticoagulation system: a novel actively controlled factor IX inhibitor using RNA aptamer technology for treatment of acute coronary syndrome.

Authors:  John Paul Vavalle; Mauricio G Cohen
Journal:  Future Cardiol       Date:  2012-03-15

Review 2.  Massive bleeding in cardiac surgery. Definitions, predictors and challenges.

Authors:  A Petrou; P Tzimas; S Siminelakis
Journal:  Hippokratia       Date:  2016 Jul-Sep       Impact factor: 0.471

3.  Effects of opium addiction on bleeding after coronary artery bypass graft surgery: report from Iran.

Authors:  Mohammad Hassan Nemati; Behrooz Astaneh; Gholamreza Safaee Ardekani
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-09-22

4.  Clinical and economic outcomes associated with blood transfusions among elderly Americans following coronary artery bypass graft surgery requiring cardiopulmonary bypass.

Authors:  Michael Lee Ganz; Ning Wu; James Rawn; Chris Leo Pashos; Martin Strandberg-Larsen
Journal:  Blood Transfus       Date:  2013-02-06       Impact factor: 3.443

Review 5.  Continuous Noninvasive Hemoglobin Monitoring: A Measured Response to a Critical Review.

Authors:  Steven J Barker; Aryeh Shander; Michael A Ramsay
Journal:  Anesth Analg       Date:  2016-02       Impact factor: 5.108

6.  Economic Analysis of the Reduction of Blood Transfusions during Surgical Procedures While Continuous Hemoglobin Monitoring Is Used.

Authors:  Borja Ribed-Sánchez; Cristina González-Gaya; Sara Varea-Díaz; Carlos Corbacho-Fabregat; Jaime Pérez-Oteyza; Cristóbal Belda-Iniesta
Journal:  Sensors (Basel)       Date:  2018-04-27       Impact factor: 3.576

7.  Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery.

Authors:  Aly Makram Habib; Ahmed Yehia Mousa; Zohair Al-Halees
Journal:  J Saudi Heart Assoc       Date:  2016-04-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.